Metrics as of 10/14/2026, 03:04 PM (Berlin time), refresh in progress.
Precipio Stock
Precipio, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Ilan Danieli
- Employees
- 61
- Market cap
- $39 M
- IPO
- 30/06/2017
Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture…
Precipio stock: price history
1D
-2.6%
1W
-6.4%
1M
-19.2%
6M
-25.4%
YTD
-4.2%
1Y
+29.5%
2Y
+242.3%
5Y
-57.0%
10Y
–
Next earnings date
Next earnings date
16/11/2026 (in 30 days)
Volatility around earnings
~38% weaker price swings than usual
Ask the agents about Precipio
Precipio stock metrics
P/E
-33.86
P/B
2.67
EV/EBITDA
65.87
RETURN ON EQUITY
-1.5%
NET MARGIN
-3.1%
DEBT/EQUITY
0.23
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
78.5%
FLOAT SHARES
1,400,834
AVG. DAILY VOLUME (30D)
110,509
Insider transactions (SEC)
Cohen David Seth
Cossman Jeffrey
Valauri Christina Rizopoulos
SANDBERG RICHARD A
SANDBERG RICHARD A
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Precipio stock
What does Precipio do?
Precipio, Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Ilan Danieli, the company employs around 61 people.
The IPO was on 30/06/2017; the stock trades on NASDAQ under the ticker PRPO.
When does Precipio report next?
The next earnings date is 16/11/2026.
Around past earnings, price swings were roughly -38% stronger than usual.
Does Precipio pay a dividend?
No, Precipio currently does not pay a dividend.
Which stocks are comparable to Precipio?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get Precipio stock analyzed?
Clicking "Analyze stock" lets five strategies assess Precipio against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.